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A Mouse Keratin 1 Mutation Causes Dark Skin
and Epidermolytic Hyperkeratosis
Kelly A. McGowan1, Swaroop Aradhya1, Helmut Fuchs2, Martin H. de Angelis2 and Gregory S. Barsh1
Chemical mutagenesis in the mouse has increased the utility of phenotype-driven genetics as a means for
studying different organ systems, developmental pathways, and pathologic processes. From a large-scale screen
for dominant phenotypes in mice, a novel class of pigmentation mutants was identified by dark skin (Dsk). We
describe a Dsk mutant, Dsk12, which models the human disease, epidermolytic hyperkeratosis (EHK). At 2 days
of age, mutant animals exhibit intraepidermal blisters and erosions at sites of trauma, and by 2 weeks of age
develop significant hyperkeratosis. We identified a missense mutation in mutant animals that predicts an S194P
amino acid substitution in the 1A domain of Keratin 1, a known target for human mutations that cause EHK.
Dsk12 recapitulates the gross pathologic, histologic, and genetic aspects of the human disorder, EHK.
Journal of Investigative Dermatology (2006) 126, 1013–1016. doi:10.1038/sj.jid.5700241; published online 9 March 2006
INTRODUCTION
Positional cloning of mouse mutations ascertained because of
a specific phenotype is a powerful approach for studying
genes involved in a defined cellular or developmental
pathway. To increase the number of entry points towards
this goal, large-scale mutagenesis projects have been initiated
in several centers (Hrabe de Angelis et al., 2000; Nolan et al.,
2000; Shiroishi, 2001; Clark et al., 2004). The screen in
Neuherberg, Germany, is a dominant screen focused on
dysmorphology, in which nearly 10% of the mutations affect
hair or skin color. We are interested in a new class of
pigmentation mutants identified by virtue of exhibiting dark
skin (Dsk) in the ears, footpads, and/or tails, and have
previously described the pathologic and genetic character-
ization of 10 dominant Dsk mutants (Fitch et al., 2003).
While a majority of these mutants map to locations in the
genome not known to be associated with cutaneous
phenotypes, we previously identified mutations in Keratin
2e (Krt2e) and epidermal growth factor receptor (Egfr) in
two Dsk mutants which serve as useful models of human
disease: the rare Krt disorder, ichthyosis bullosa of Siemens
(Krt2e), and epidermal growth factor receptor-dependent
carcinogenesis.
Here we describe a new mutant, Dsk12, that models the
human disease, epidermolytic hyperkeratosis (EHK). While
Dsk12 was identified by increased footpad pigmentation in
heterozygous animals at 2 months of age, marked blistering
and hyperkeratosis develop during postnatal life, a phenotype
very similar to the human condition EHK. We describe the
whole animal, histologic, and molecular genetic character-
ization of Dsk12, and identify a missense alteration in the 1A
domain of Keratin 1 (Krt1).
RESULTS
Dsk12 was identified by the presence of excess pigmentation
in heterozygous animals at 2 months of age (Figure 1a and b).
The increase in pigmentation is located on the volar pads, the
intervolar pad scales, and the digital tips. Histologic analysis
of mutant footpads shows hyperkeratosis, acanthosis, and
increased epidermal pigment located at the tips of the rete
ridges and within the eccrine ducts (Figure 1c and d). These
gross and histologic phenotypes are similar to other Class II
mouse pigmentation mutants (a classification scheme de-
scribed by Fitch et al. (2003)), which are characterized by an
accumulation of epidermal pigment.
Immediately after birth, Dsk12/þ animals develop blisters
and erosions at sites of friction, including the footpad and
tail (Figure 1e and f and data not shown). Infrequently,
Dsk12/þ animals have small erosions and scaling on the
body, but, like other Krt1 and Krt 10 mouse mutants (Porter
et al., 1996; Arin et al., 2001; Arin and Roop, 2004), scaling
and blistering on the body diminishes with the onset of
hair growth. Histological examination of lesional skin shows
an intraepidermal blister and disintegration of spinous
keratinocytes. After several days, serous crust and regenerat-
ing keratinocytes cover the ruptured blister (Figure 1g and h).
By 2 weeks of age, erosions are replaced by marked scaling
(Figure 1i and j), and the footpad epidermis is characterized
by hyperkeratosis, acanthosis, and keratinocyte cytolysis
(Figure 1k and l). Hyperkeratotic areas on the footpads
develop into thick, brown hyperkeratotic plaques in adult
animals.
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We also characterized the phenotype of Dsk12 homo-
zygotes, which exhibit a more severe blistering phenotype
than heterozygotes at birth, with small skin erosions in some
pups and widespread desquamation in others (Figure 2a–c).
Animals with extensive blistering appear dehydrated and
either die spontaneously or are cannibalized; no Dsk12/
Dsk12 animals were recovered after 21 days of age (Table 1).
We used a combined intercross and backcross strategy to
map Dsk12 to the distal end of chromosome 15. The
proximal boundary is defined by a crossover between
Dsk12 and D15Mit43 that was recovered in a Dsk12/þ
animal; the distal boundary is defined by the end of
chromosome 15. This defines a critical interval of B5.6 Mb
(from D15Mit43 at 98,066,137 to the end of chromosome 15
at 103,696,402) that contains B100 genes.
In this region, we considered Krt1 as the most likely
candidate because the Dsk12/þ phenotype mimics the gross
and histologic features of Krt1 (and Krt10) mutant mice:
blistering at birth that diminishes with the onset of hair
growth, leaving thick, brown, hyperkeratotic plaques on the
paws (Bickenbach et al., 1996; Porter et al., 1996; Arin et al.,
























Figure 1. Dsk12 heterozygous phenotype. (a, b) Dsk12/þ footpads are
darker than nonmutant littermates at 2 months of age. (c, d) Histologic
analysis of Dsk12/þ footpads shows hyperkeratosis, acanthosis, and
increased epidermal pigment (black arrow). (e, f) At 2 days of age, blistering
and erosions are apparent, and (g, h) an intraepidermal separation and serous
crust are observed. (i, j) 2-week old Dsk12/þ footpads, are characterized by
scaling. (k, l) Histology shows hyperkeratosis, acanthosis, and keratinocyte
cytolysis. (a, b, i, j) Bar¼2 mm, (c, d) bar¼125 mm, (e, f) bar¼500 mm,
(g, h) bar¼ 75 mm, (k, l) bar¼ 50 mm.
a b c
+/+ Dsk12/Dsk12 (mild) Dsk12/Dsk12 (severe)
Figure 2. Dsk12 homozygous phenotype. (a–c) Dsk12/Dsk12 newborn pups
show signs of skin fragility. (b) Some pups are born with small erosions,
(c) while others have generalized bullae and erosions. (b–c) Bar¼ 2.5 mm.
Table 1. Observed genotype frequencies from Dsk12/
+ intercrosses
Age +/+1 Dsk12/+ Dsk12/Dsk12
Newborn (P0.5) 17 31 72
Adult (P21)3 29 40 0
1Animals were genotyped using flanking polymorphic markers on F1
intercross progeny or an MaeIII restriction fragment length polymorphism
on inbred animals.
23/7 Dsk12/Dsk12 newborn animals expired at birth.
3Values differ from expected Mendelian ratio (Po0.001 using w2 statistical
test).
+/+
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Dsk12 /Dsk12
Human missense alterations in epidermolytic hyperkeratosis




Figure 3. A mutation in basic Krt1 in Dsk12. (a) Sequencing of genomic
DNA from nonmutant and mutant animals reveals a T-C transition in exon 1
of Krt1 (NM_008473). (b) The Dsk12 base pair change predicts a S194P
missense mutation in the highly conserved 1A domain of Krt1 (red arrow).
Human missense alterations in patients with EHK are indicated (black arrows)
(http://uwcmml1s.uwcm.ac.uk/uwcm/mg/search/128198.html).
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candidate because, like Krt1, Krt2e is expressed in the
suprabasal epidermis, and we have previously identified a
missense mutation in Krt2e in another Dsk mutant (Dsk2) that
causes epidermal thickening and suprabasal blistering (Fitch
et al., 2003).
Using PCR amplification of genomic DNA and
direct sequencing of Krt1 and Krt2e exons from nonmutant
and mutant animals, we identified a missense mutation
that predicts a S194P substitution in the 1A domain of Krt1
(Figure 3a). This region is known to be important for acidic
Krt–basic Krt interactions during the formation of Krt
intermediate filaments (Coulombe et al., 1990; Wilson
et al., 1992), and is a domain where a number of missense
mutations in human patients with EHK have been identi-
fied (Figure 3b). Surprisingly, this exact mutation has
been reported in a human patient with EHK (McLean et al.,
1994).
DISCUSSION
Dsk12 mutant mice exhibit many of the hallmarks of the
human Krt disorder EHK (Bale et al., 1993). Like affected
patients, Dsk12 mutant animals present with blistering and
erosions at birth; pathological examination of lesional skin
shows suprabasal keratinocyte lysis and a thickened stratum
corneum. Although Dsk12 was identified as a pigmentary
abnormality, humans affected with EHK also develop brown
hyperkeratotic plaques in areas exposed to mechanical
trauma later in life (DiGiovanna, 1999). Every reported case
of EHK has been associated with a mutation in either KRT1 or
KRT10, and the mutations often affect the helix initiation or
termination motifs (1A and 2B, respectively). Thus, Dsk12 is a
model for EHK at the whole animal, pathologic, and
molecular genetic levels.
Secondary structure predictions carried out by McLean
et al. (1994) indicate the S185P mutation in a human patient
affected with EHK is likely to disrupt the a-helical structure of
the 1A domain and interfere with KRT1–KRT10 interactions
during intermediate filament formation. Although we have
not carried out biochemical studies on the Krt1 S194P
mutation, it is orthologous to the S185P mutation in human
KRT1 and therefore likely to act in a similar manner. Finally,
the mouse and the human conditions are manifest in
heterozygotes. Although humans with homozygous EHK
have not been described, the semidominant nature of
Dsk12 suggests that KRT1 or KRT10 missense alterations in
the interaction domain would be more severe in homozygous
than in heterozygous form.
Several approaches have been used to generate mouse
models of EHK, including expression of a truncated KRT14
transgene (Fuchs et al., 1992), expression of a truncated KRT1
transgene (Bickenbach et al., 1996), and conditional expres-
sion of a mutant Krt10 gene using gene targeting and site-
specific recombination (Arin et al., 2001; Arin and Roop,
2004). These studies have led to substantial insight into the
molecular pathogenesis of blistering diseases caused by Krt
abnormalities, and provide the foundation for our specula-
tions regarding the mechanism of action in Dsk12 mutant
mice.
The mechanism by which brown hyperkeratosis develops
in Krt1 or Krt10 mouse mutants and in human patients with
EHK is unknown. While the contribution of the thick
epidermis to skin darkening has not been investigated, some
investigators have proposed that scale pigmentation is due to
a deficiency of melanosome degradation (Mesquita-Guimar-
aes, 1981). Our own studies of Dsk2, a Krt2e mutation that
mimics icthyosis bullosa of Siemens, suggest that skin
darkening in Dsk12 may be due to an increased number of
melanocytes in affected skin (Fitch et al., 2003). Since
epidermal thickening is apparent several weeks before dark
skin in Dsk2 and Dsk12 animals, we speculate that
proliferating basal keratinocytes release one or more para-
crine factors that stimulate the proliferation of adjacent
pigment cells.
Together with our earlier work (Fitch et al., 2003), the
current studies of Dsk12 suggest that dark skin in mice may
provide a sensitive and specific signature for disorders of
keratinization. Additional mutants similar to Dsk2 and Dsk12
will almost certainly lead to new Krt mutants, and, in
addition, may provide a means to identify additional
molecular components required for normal keratinization.
MATERIALS AND METHODS
Mouse genetics
Like other animals from the original mutagenesis project (http://
www.gsf.de/ieg), Dsk12/þ was generated using ethylnitrosourea,
and maintained on a C3HeB/FeJ inbred background. For genetic
mapping, genomic DNA from four mutant backcross progeny
((C3HeB/FeJ-Dsk12/þ C57BL/6J) F1C3HeB/FeJ) animals was
pooled and compared to a pool of wild-type backcross progeny
using a panel of 81 genome-wide simple sequence length
polymorphisms spaced B15 cM apart (marker sequences available
on request). Linkage to distal chromosome 15 was verified using 18
backcross and 17 F2 intercross progeny that were scored for the Dsk
phenotype at 2 months of age. (As described below, Dsk12 mutant
animals also exhibit blistering; however, the genetic mapping was
based solely on the Dsk phenotype.) Relationship between genetic
and physical distances was evaluated with the March 2005 release of
the mouse genome sequence (http://genome.ucsc.edu). The experi-
ments in this study were approved by the Stanford Administrative
Panel on Laboratory Animal Care.
Histology
Skin from 2-day-, 2-week-, and 2-month-old mutant and nonmutant
littermates was removed from the footpads and tails, fixed in 4%
paraformaldehyde, and embedded in paraffin. Sections of 10 mM
were taken, stained with hematoxylin and eosin, and examined by
light microscopy. The footpad was sectioned in entirety for at least
three mutant and nonmutant animals at each time point.
Molecular genetics
Genomic DNA from þ /þ and Dsk12/Dsk12 animals was used for
PCR amplification and direct sequencing of Krt1 and Krt2e coding
exons (NM_008473 and NM_010668). Animals were genotyped
using an MaeIII restriction fragment length polymorphism that is
absent in mutant animals.
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